31
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Regulation of PrP C signaling and processing by dimerization

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The cellular prion protein (PrP C) is a glycosylphosphatidylinositol (GPI)-anchored protein present at the cell surface. PrP C N-terminal moiety is intrinsically disordered and is able to interact with a variety of ligands. Physiological ligands have neurotrophic activity, whilst others, including protein toxic oligomers, have neurotoxic functions. These two opposite activities involve different interacting partners and result from different PrP C-activated signaling pathways. Remarkably, PrP C may be inactivated either by physiological endoproteolysis and release of the N-terminal domain, or by ectodomain shedding. Ligand-induced PrP C dimerization or enforced dimerization of PrP C indicate that PrP C dimerization represents an important molecular switch for both intracellular signaling and inactivation by the release of PrP C N-terminal domain or shedding. In this review, we summarize evidence that cell surface receptor activity of PrP C is finely regulated by dimerization.

          Related collections

          Most cited references54

          • Record: found
          • Abstract: found
          • Article: not found

          Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis.

          The mechanisms involved in prion neurotoxicity are unclear, and therapies preventing accumulation of PrPSc, the disease-associated form of prion protein (PrP), do not significantly prolong survival in mice with central nervous system prion infection. We found that depleting endogenous neuronal PrPc in mice with established neuroinvasive prion infection reversed early spongiform change and prevented neuronal loss and progression to clinical disease. This occurred despite the accumulation of extraneuronal PrPSc to levels seen in terminally ill wild-type animals. Thus, the propagation of nonneuronal PrPSc is not pathogenic, but arresting the continued conversion of PrPc to PrPSc within neurons during scrapie infection prevents prion neurotoxicity.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Dimerization of cell surface receptors in signal transduction.

            C-H Heldin (1995)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Anchorless prion protein results in infectious amyloid disease without clinical scrapie.

              In prion and Alzheimer's diseases, the roles played by amyloid versus nonamyloid deposits in brain damage remain unresolved. In scrapie-infected transgenic mice expressing prion protein (PrP) lacking the glycosylphosphatidylinositol (GPI) membrane anchor, abnormal protease-resistant PrPres was deposited as amyloid plaques, rather than the usual nonamyloid form of PrPres. Although PrPres amyloid plaques induced brain damage reminiscent of Alzheimer's disease, clinical manifestations were minimal. In contrast, combined expression of anchorless and wild-type PrP produced accelerated clinical scrapie. Thus, the PrP GPI anchor may play a role in the pathogenesis of prion diseases.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Cell Dev Biol
                Front Cell Dev Biol
                Front. Cell Dev. Biol.
                Frontiers in Cell and Developmental Biology
                Frontiers Media S.A.
                2296-634X
                25 August 2014
                09 October 2014
                2014
                : 2
                : 57
                Affiliations
                Department of Biochemistry, Faculty of Medicine, Université de Sherbrooke Sherbrooke, QC, Canada
                Author notes

                Edited by: Sophie Mouillet-Richard, Institut National de la Santé et de la Recherche Médicale, France

                Reviewed by: Markus Glatzel, University Medical Center Hamburg-Eppendorf, Germany; Joel Watts, University of Toronto, Canada

                *Correspondence: Xavier Roucou, Département de Biochimie (Z8-2001), Faculté de Médecine, Université de Sherbrooke, 3201 Jean Mignault, Sherbrooke, QC J1E4K8, Canada e-mail: xavier.roucou@ 123456usherbrooke.ca

                This article was submitted to Cell Death and Survival, a section of the journal Frontiers in Cell and Developmental Biology.

                Article
                10.3389/fcell.2014.00057
                4207009
                24aa05db-76a4-4197-b38b-79e265cc6fdb
                Copyright © 2014 Roucou.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 04 August 2014
                : 19 September 2014
                Page count
                Figures: 1, Tables: 0, Equations: 0, References: 61, Pages: 6, Words: 5111
                Categories
                Cell and Developmental Biology
                Mini Review Article

                prion protein trafficking,dimerization,signaling,neuroprotection,neurodegeneration

                Comments

                Comment on this article